Skip to content

A single-center randomized controlled study on the early intervention of urinary incontinence after prostate surgery using visual precision electrophysiological diagnosis and treatment technology

A single-center randomized controlled study on the early intervention of urinary incontinence after prostate surgery using visual precision electrophysiological diagnosis and treatment technology

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300078810
Enrollment
Unknown
Registered
2023-12-19
Start date
2023-12-19
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post-prostatectomy incontinence

Interventions

The experimental group:50 times of traditional levator training + qd × 10 times of electrophysiological intervention per day
The control group:50 traditional levator exercises per day for 10 days.

Sponsors

Dongguan city people's hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1, PPI. 2, men aged 18 or above. 3, participants are willing to during the study period, do not accept physical therapy and other except experimental drugs required medication, can regularly; January - march - June.

Exclusion criteria

Exclusion criteria: 1. Preoperative stimulation due to complex pathological, psychological, social and other factors, or previous surgical injury, postoperative coma, central or peripheral nerve damage, paralysis, stroke, Alzheimer's disease, abnormal urethral continence mechanism, Aging of the body, age and menopausal status, childbirth, and chronic increase in abdominal pressure: factors such as long-term constipation, chronic respiratory diseases, obesity, and long-term weight-bearing can cause urinary incontinence. 2. You are using certain drugs that you take for a long time and will affect the treatment of urinary incontinence, such as a1-adrenergic agonists, tricyclic antidepressants, topical estrogen treatment, etc. 3. Subjects who have difficulty understanding and complying with the plan due to various reasons, such as poor understanding, mental disorder, language barrier, etc. 4. Subjects who are likely to cause doctor-patient disputes. 5. Subjects who are participating in other experimental studies. 6. Those who meet the

Design outcomes

Primary

MeasureTime frame
International Urinary Incontinence Questionnaire score;24 hour urine pad test;

Secondary

MeasureTime frame
Scores of prostate;Blood routine;

Countries

China

Contacts

Public ContactLUO DAOSHENG

Dongguan city people's hospital

zdluods@126.com+86 136 2009 5111

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026